Details for 2020713873
Up to date per 04.04.2026
Actions
Details for 2020713873
Granted/Registered
European Patent
09.02.2022 A
31.08.2022 B1
29.03.2019
US
201962826393 P
22.01.2020
US
202062964177 P
A61K 47/68 20170101AFI20201009BHEP
Owner
MedImmune LimitedMilstein Building Granta Park Cambridge Cambridgeshire CB21 6GHGB
Representative
Representative
Häupl & Ellmeyer KG, PatentanwaltskanzleiMariahilfer Straße 50 (Kirchengasse 1)1070 WienAT
Inventor
HOWARD, Philip, Wilsonc/o MedImmune Limited Milstein Building, Granta Park Cambridge Cambridgeshire CB21 6GHGB
DICKINSON, Niallc/o MedImmune Limited Milstein Building, Granta Park Cambridge Cambridgeshire CB21 6GHGB
CAILLEAU, Thaisc/o MedImmune Limited Milstein Building, Granta Park Cambridge Cambridgeshire CB21 6GHGB
MASTERSON, Lukec/o MedImmune Limited Milstein Building, Granta Park Cambridge Cambridgeshire CB21 6GHGB
GOUNDRY, Williamc/o AstraZeneca 1 Francis Crick Avenue, Cambridge Biomedical Campus Cambridge Cambridgeshire CB2 0AAGB
Information about Fees